최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Clinical and vaccine immunology : CVI, v.20 no.3, 2013년, pp.319 - 327
D'Elia, Riccardo V. (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom) , Harrison, Kate (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom) , Oyston, Petra C. (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom) , Lukaszewski, Roman A. (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom) , Clark, Graeme C. (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom)
Inflammation is the body's first line of defense against infection or injury, responding to challenges by activating innate and adaptive responses. Microbes have evolved a diverse range of strategies to avoid triggering inflammatory responses. However, some pathogens, such as the influenza virus and...
Eur. Heart J. Kalden 8 1 1987 10.1093/eurheartj/8.suppl_J.1 What is inflammation?
Nature Medzhitov 449 819 2007 10.1038/nature06246 Recognition of microorganisms and activation of the immune response
Anaesth. Intensive Care Lilic 10 218 2009 10.1016/j.mpaic.2009.01.013 Immune response to infection
J. Clin. Invest. Barton 118 413 2008 10.1172/JCI34431 A calculated response: control of inflammation by the innate immune system
Immunity Kato 23 19 2005 10.1016/j.immuni.2005.04.010 Cell type-specific involvement of RIG-I in antiviral response
Nat. Immunol. Yoneyama 5 730 2004 10.1038/ni1087 The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
Immunol. Lett. Heine 139 14 2011 10.1016/j.imlet.2011.04.010 TLRs, NLRs and RLRs: innate sensors and their impact on allergic diseases-a current view
J. Immunol. Couper 180 5771 2008 10.4049/jimmunol.180.9.5771 IL-10: the master regulator of immunity to infection
Nat. Rev. Immunol. Chen 10 826 2010 10.1038/nri2873 Sterile inflammation: sensing and reacting to damage
J. Invest. Surg. Speyer 24 18 2011 10.3109/08941939.2010.521232 Role of endothelial chemokines and their receptors during inflammation
Blood Murdoch 95 3032 2000 10.1182/blood.V95.10.3032 Chemokine receptors and their role in inflammation and infectious diseases
Curr. Opin. Hematol. Zeilhofer 7 178 2000 10.1097/00062752-200005000-00009 Role of interleukin-8 in neutrophil signaling
Nat. Rev. Neurosci. Dantzer 9 46 2008 10.1038/nrn2297 From inflammation to sickness and depression: when the immune system subjugates the brain
Chest Opal 117 1162 2000 10.1378/chest.117.4.1162 Anti-inflammatory cytokines
Mediators Inflamm. Chung 10 51 2001 10.1080/09629350120054518 Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma
Pharmacol. Rev. Asadullah 55 241 2003 10.1124/pr.55.2.4 Interleukin-10 therapy-review of a new approach
Cell Finlay 124 767 2006 10.1016/j.cell.2006.01.034 Anti-immunology: evasion of the host immune system by bacterial and viral pathogens
Mikrobiyol. Bul. Us 42 365 2008 Cytokine storm in avian influenza
Infect. Immun. Mares 76 3001 2008 10.1128/IAI.00215-08 Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns
Crit. Care de Castro 14 115 2010 10.1186/cc8846 First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1
Microbiol. Mol. Biol. Rev. Tisoncik 76 16 2012 10.1128/MMBR.05015-11 Into the eye of the cytokine storm
10.1371/journal.ppat.1000115 PerroneLAPlowdenJKGarcia-SastreAKatzJMTumpeyTM. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4:e1000115. doi:10.1371/journal.ppat.1000115.
J. Infect. Dis. Wang 202 991 2010 10.1086/656044 Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza
Respir. Physiol. Neurobiol. Cheng 175 185 2011 10.1016/j.resp.2010.11.004 Three fatal cases of pandemic 2009 influenza A virus infection in Shenzhen are associated with cytokine storm
Microb. Pathog. Sharma 51 39 2011 10.1016/j.micpath.2011.03.007 Features of sepsis caused by pulmonary infection with Francisella tularensis type A strain
Nat. Rev. Microbiol. Oyston 2 967 2004 10.1038/nrmicro1045 Tularaemia: bioterrorism defence renews interest in Francisella tularensis
J. Immunol. Bosio 178 4538 2007 10.4049/jimmunol.178.7.4538 Active suppression of the pulmonary immune response by Francisella tularensis Schu4
Mol. Immunol. Conlan 45 2962 2008 10.1016/j.molimm.2008.01.022 Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis
Br. J. Exp. Pathol. Fleming 10 226 1929 On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae
Annu. Rev. Med. Shenoi 60 307 2009 10.1146/annurev.med.60.053107.103955 Extensively drug-resistant tuberculosis: a new face to an old pathogen
Respirology Udwadia 17 741 2012 10.1111/j.1440-1843.2012.02192.x Totally drug-resistant tuberculosis in India: Who let the djinn out?
Br. J. Pharmacol. Coates 152 1147 2007 10.1038/sj.bjp.0707432 Novel approaches to developing new antibiotics for bacterial infections
Science Fischbach 325 1089 2009 10.1126/science.1176667 Antibiotics for emerging pathogens
Virus Res. Parker 107 165 2005 10.1016/j.virusres.2004.11.006 Metabolism and antiviral activity of ribavirin
Curr. Opin. Infect. Dis. Cameron 14 757 2001 10.1097/00001432-200112000-00015 The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase
J. Virol. Moreno 85 7246 2011 10.1128/JVI.00614-11 Ribavirin can be mutagenic for arenaviruses
Antimicrob. Agents Chemother. Piret 55 459 2011 10.1128/AAC.00615-10 Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management
Trends Biotechnol. Kutateladze 28 591 2010 10.1016/j.tibtech.2010.08.001 Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Emerg. Infect. Dis. Casadevall 2 200 1996 10.3201/eid0203.960306 Antibody-based therapies for emerging infectious diseases
Expert Opin. Ther. Pat. Masihi 13 867 2003 10.1517/13543776.13.6.867 Progress on novel immunomodulatory agents for HIV-1 infection and other infectious diseases
Drugs Foster 70 147 2010 10.2165/11531990-000000000-00000 Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b
Br. J. Clin. Pharmacol. Khakoo 46 563 1998 10.1046/j.1365-2125.1998.00836.x Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions
J. Immunol. Elkins 162 2291 1999 10.4049/jimmunol.162.4.2291 Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria
Infect. Immun. Waag 74 1944 2006 10.1128/IAI.74.3.1944-1948.2006 A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei
Infect. Immun. Wongratanacheewin 72 4494 2004 10.1128/IAI.72.8.4494-4502.2004 Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei
10.1186/1476-8518-8-2 RozakDAGelhausHCSmithMZadehMHuzellaLWaagDAdamoviczJJ. 2010. CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols. J. Immune Based Ther. Vaccines 8:2. doi:10.1186/1476-8518-8-2.
J. Cell. Biochem. Dinarello 39 229 1989 10.1002/jcb.240390303 Role for interleukin-1 in the pathogenesis of hypersensitivity diseases
Surgery Michie 104 280 1988 Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings
Blood Crown 78 1420 1991 10.1182/blood.V78.6.1420.1420 A phase I trial of recombinant human interleukin-1-beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
Shock Song 30 468 2008 10.1097/SHK.0b013e31816d5e49 The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats
Clin. Exp. Immunol. Yoshikawa 146 116 2006 10.1111/j.1365-2249.2006.03169.x Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappa B phosphorylation and nuclear factor-kappa B transcriptional activity through nicotinic acetylcholine receptor alpha 7
Nature Borovikova 405 458 2000 10.1038/35013070 Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
J. Thromb. Haemost. Van Westerloo 4 1997 2006 10.1111/j.1538-7836.2006.02112.x Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats
J. Immunol. Matsunaga 167 6518 2001 10.4049/jimmunol.167.11.6518 Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine
Int. Immunopharmacol. Mamata 5 749 2005 10.1016/j.intimp.2004.12.010 Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells
Behav. Brain Res. Kem 113 169 2000 10.1016/S0166-4328(00)00211-4 The brain alpha 7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)
Psychopharmacology Martin 174 54 2004 10.1007/s00213-003-1750-1 Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Am. J. Psychiatry Freedman 165 1040 2008 10.1176/appi.ajp.2008.07071135 Initial phase 2 trial of a nicotinic agonist in schizophrenia
Crit. Care Med. Pavlov 35 1139 2007 10.1097/01.CCM.0000259381.56526.96 Selective alpha 7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis
Biochem. Pharmacol. Kox 78 863 2009 10.1016/j.bcp.2009.06.096 GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation
Shock Kox 36 5 2011 10.1097/SHK.0b013e3182168d56 Effects of the alpha 7 nicotinic acetylcholine receptor agonist Gts-21 on the innate immune response in humans
J. Endotoxin Res. Villa 4 197 1997 10.1177/096805199700400305 Protection against lethal polymicrobial sepsis by CNI-1493, an inhibitor of pro-inflammatory cytokine synthesis
J. Microencapsul. Oettinger 27 372 2010 10.3109/02652040903243437 Synergism in survival to endotoxic shock in rats given microencapsulated CNI-1493 and antisense oligomers to NF-kappa B
Curr. Opin. Infect. Dis. Yoshikai 14 257 2001 10.1097/00001432-200106000-00003 Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection
Shock Strong 14 374 2000 10.1097/00024382-200014030-00023 Blocking prostaglandin E-2 after trauma attenuates pro-inflammatory cytokines and improves survival
10.1371/journal.pone.0011610 CareyMABradburyJARebollosoYDGravesJPZeldinDCGermolecDR. 2010. Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. PLoS One 5:e11610. doi:10.1371/journal.pone.0011610.
J. Infect. Dis. Lee 198 525 2008 10.1086/590499 Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection
Thorax Lauder 66 368 2011 10.1136/thx.2010.150318 Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
Proc. Natl. Acad. Sci. U. S. A. Zheng 105 8091 2008 10.1073/pnas.0711942105 Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Discov. Med. Garcia 10 479 2010 The development of anti-inflammatory drugs for infectious diseases
Crit. Care Med. Zimmerman 30 S294 2002 10.1097/00003246-200205001-00020 The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis
Biochimie Yost 92 692 2010 10.1016/j.biochi.2010.02.011 The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses
Shock Gomes 26 41 2006 10.1097/01.shk.0000209562.00070.1a Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis
Crit. Care Med. Schuster 31 1612 2003 10.1097/01.CCM.0000063267.79824.DB Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: phase IIb, multicenter, randomized, placebo-controlled, clinical trial
Crit. Care Med. Opal 32 332 2004 10.1097/01.CCM.0000108867.87890.6D Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial
Proc. Natl. Acad. Sci. U. S. A. Souza 106 14138 2009 10.1073/pnas.0906467106 Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection
Annu. Rev. Pharmacol. Toxicol. Fernandez 42 469 2002 10.1146/annurev.pharmtox.42.091901.115838 Structure junction, and inhibition of chemokines
J. Intern. Med. Baggiolini 250 91 2001 10.1046/j.1365-2796.2001.00867.x Chemokines in pathology and medicine
Biochem. Pharmacol. Ajuebor 63 1191 2002 10.1016/S0006-2952(02)00854-7 Chemokines as novel therapeutic targets in inflammatory diseases
Infect. Immun. Nakano 62 377 1994 10.1128/IAI.62.2.377-383.1994 Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor
J. Leukoc. Biol. Strieter 57 752 1995 10.1002/jlb.57.5.752 Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
J. Immunol. Laning 153 4625 1994 10.4049/jimmunol.153.10.4625 Inhibition of in vivo tumor growth by the beta chemokine, TCA3
Nat. Med. Premack 2 1174 1996 10.1038/nm1196-1174 Chemokine receptors: gateways to inflammation and infection
Genome Biol. Zlotnik 7 243 2006 10.1186/gb-2006-7-12-243 The chemokine and chemokine receptor superfamilies and their molecular evolution
Eur. J. Immunol. Tran 30 1410 2000 10.1002/(SICI)1521-4141(200005)30:5<1410::AID-IMMU1410>3.0.CO;2-L Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor
Methods Karpus 29 362 2003 10.1016/S1046-2023(02)00360-2 Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease
J. Immunol. Lin 186 508 2011 10.4049/jimmunol.1001002 CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection
Immunology Reckless 103 244 2001 10.1046/j.1365-2567.2001.01228.x The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo
Nat. Med. O'Garra 10 801 2004 10.1038/nm0804-801 Regulatory T cells and mechanisms of immune system control
Nat. Rev. Immunol. Bluestone 3 253 2003 10.1038/nri1032 Natural versus adaptive regulatory T cells
Immunol. Rev. Shevach 212 60 2006 10.1111/j.0105-2896.2006.00415.x The lifestyle of naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells
Blood Deaglio 109 5390 2007 10.1182/blood-2006-12-061812 CD38/CD19: a lipid raft-dependent signaling complex in human B cells
Nat. Immunol. Fontenot 4 330 2003 10.1038/ni904 Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells
J. Exp. Med. Fontenot 202 901 2005 10.1084/jem.20050784 Developmental regulation of Foxp3 expression during ontogeny
J. Clin. Invest. Chatila 106 R75 2000 10.1172/JCI11679 JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome
Nat. Genet. Bennett 27 20 2001 10.1038/83713 The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
Curr. Opin. Pediatr. Bennett 13 533 2001 10.1097/00008480-200112000-00007 IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena
Science Hori 299 1057 2003 10.1126/science.1079490 Control of regulatory T cell development by the transcription factor Foxp3
J. Allergy Clin. Immunol. Akdis 116 961 2005 10.1016/j.jaci.2005.09.004 T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases
Immunology Taams 118 1 2006 10.1111/j.1365-2567.2006.02348.x Regulatory T cells in human disease and their potential for therapeutic manipulation
Immunol. Rev. Brusko 223 371 2008 10.1111/j.1600-065X.2008.00637.x Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
J. Exp. Med. Serhan 192 1197 2000 10.1084/jem.192.8.1197 Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing
Nature Schwab 447 869 2007 10.1038/nature05877 Resolvin E1 and protectin D1 activate inflammation-resolution programmes
J. Exp. Med. Serhan 196 1025 2002 10.1084/jem.20020760 Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
J. Immunol. Bannenberg 174 4345 2005 10.4049/jimmunol.174.7.4345 Molecular circuits of resolution: formation and actions of resolvins and protectins
J. Biol. Chem. Sun 282 9323 2007 10.1074/jbc.M609212200 Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation
Proc. Natl. Acad. Sci. U. S. A. Arita 102 7671 2005 10.1073/pnas.0409271102 Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
J. Immunol. Duffield 177 5902 2006 10.4049/jimmunol.177.9.5902 Resolvin D series and protectin D1 mitigate acute kidney injury
※ AI-Helper는 부적절한 답변을 할 수 있습니다.